Use Biovail Corporation money management together with your portfolio to hedge against foreign markets instabilities and to determine Fund optimization strategy that fits your criteria.
Mr. Philip W. Loberg is Executive Vice President of Valeant Pharmaceuticals International Inc. He resigned from the position of Interim Chief Financial Officer of the Company with effective December 1, 2011...
Mr. Rajiv De Silva is President, Chief Operating Officer Specialty Pharmaceuticals of Valeant Pharmaceuticals International Inc. He was the President of the Company and Chief Operating Officer of Specialty Pharmaceutical...
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Management
Discussion
